Fu-Dong Shi | Neuroimmunology | Best Researcher Award

Published on by China Scientist

Prof. Fu-Dong Shi | Neuroimmunology | Best Researcher Award

Dr. Fu-Dong Shi is a distinguished neurologist and Professor of Neurology at Beijing Tiantan Hospital and Tianjin Medical University General Hospital. With extensive training from institutions like Peking Union Hospital and the Karolinska Institute, he specializes in neuroinflammatory disorders, particularly multiple sclerosis, neuromyelitis optica, myasthenia gravis, and inflammatory neuropathy. Dr. Shi has published over 300 articles in leading journals and has been recognized with membership in the Academia Europaea. He is a prominent leader in clinical neuroimmunology, contributing to groundbreaking research, clinical trials, and the development of diagnostic and therapeutic interventions.

Prof. Fu-Dong Shi | Tianjin Medical University | China

Profile

SCOPUS ID

ORCID ID

GOOGLE SCHOLAR

🎓Education

  • Dr. Fu-Dong Shi completed his clinical and research training at Peking Union Hospital, the Karolinska Institute, The Scripps Research Institute, and the Barrow Neurological Institute, gaining extensive experience in neuroinflammatory disorders.

đŸ‘šâ€đŸ«Experience

  • Dr. Shi currently serves as a Professor of Neurology at both Beijing Tiantan Hospital and Tianjin Medical University General Hospital. He is also the Chief of the Neuroimmunology Section at the Chinese Neurological Association. With a long career in academia and clinical research, he has collaborated with several prominent researchers and institutions across the globe, including the Karolinska Institute, Oxford University, CharitĂ© – UniversitĂ€tsmedizin Berlin, and leading pharmaceutical companies.

🏆Awards and Recognitions

  • Dr. Shi has been elected as a member of the Academia Europaea in 2024 for his distinguished contributions to the research and care of patients with neuroinflammatory disorders. His innovative research has earned recognition in numerous prestigious journals such as Nature Immunology, Immunity, and Nature Reviews Immunology.

💡Skills and Certifications

  • Dr. Shi is a renowned expert in the field of neuroimmunology, with specialized knowledge in the immune responses of the central nervous system. His skill set includes advanced research in multiple sclerosis, neuromyelitis optica spectrum disorders, myasthenia gravis, and inflammatory neuropathy. He has also been instrumental in developing diagnostic technologies and therapeutic interventions for these conditions.

🔬 Research Focus

  • Dr. Shi’s research primarily focuses on the clinical and basic studies of multiple sclerosis (MS), neuromyelitis optica spectrum disorders (NMOSD), myasthenia gravis (MG), and inflammatory neuropathy. His groundbreaking work has advanced the understanding of immune responses within the central nervous system, particularly in relation to brain ischemia, hemorrhage, and neuroimmune interactions. His research aims to drive innovative clinical trials testing immune interventions for neuroinflammatory disorders and exploring new diagnostic and therapeutic approaches for neuromyelitis optica and myasthenia gravis.

🌎Conclusion

  • Dr. Fu-Dong Shi’s groundbreaking research and leadership in neuroimmunology have earned him a reputation as one of the most influential researchers in the field. His work has provided valuable insights into immune system involvement in neurological diseases and led to the development of novel diagnostic and therapeutic approaches. Dr. Shi’s dedication to advancing scientific understanding and improving patient care makes him an outstanding candidate for the Best Researcher Award

📖Publications

  • Spatial structural abnormality maps associated with cognitive and physical performance in relapsing-remitting multiple sclerosis
    Authors: Z. Zhuo, N. Zhang, F. Ao, D. Tian, Y. Liu
    Journal: European Radiology, 2025

  • Multiplex proteomics identifies inflammation-related plasma biomarkers for aging and cardio-metabolic disorders
    Authors: S. Wu, Y. Li, X. Zhao, F. Shi, J. Chen
    Journal: Clinical Proteomics, 2024

  • Deep learning enables accurate brain tissue microstructure analysis based on clinically feasible diffusion magnetic resonance imaging
    Authors: Y. Li, Z. Zhuo, C. Liu, C. Ye, Y. Liu
    Journal: NeuroImage, 2024

  • Differential diagnosis of suspected multiple sclerosis: global health considerations
    Authors: J.D. Correale, A.J. Solomon, J.A. Cohen, B.I. Yamout, K. Fujihara
    Journal: [No source information available]

  • High Frequency of Autoantibodies in COVID-19 Patients with Central Nervous System Complications: a Multicenter Observational Study
    Authors: J. Lin, D. Zheng, D. Tian, F. Shi, H. Wang
    Journal: Molecular Neurobiology, 2024

Tongguo Shi | Cancer | Best Researcher Award

Published on by China Scientist

Dr. Tongguo Shi | Cancer | Best Researcher Award

Tongguo Shi is an Associate Researcher at the First Affiliated Hospital of Soochow University, specializing in cancer immunology and molecular medicine. He earned his PhD from Nanjing University in 2016 and has since focused on tumor immune evasion, immune checkpoint regulation, and colorectal cancer research. His work has been published in leading journals such as Cancer Immunology, Immunotherapy and Cell Death & Disease, with multiple studies highlighting novel therapeutic targets. With expertise in molecular biology and immunological assays, he is dedicated to advancing cancer immunotherapy and precision medicine.

Dr. Tongguo Shi | The First Affiliated Hospital of Soochow University | China

Profile

SCOPUS ID

ORCID ID

🎓Education

  • Tongguo Shi earned his PhD from Nanjing University in 2016, following his undergraduate studies at Liyi University, where he obtained a BA in 2010. His academic journey has equipped him with a strong foundation in medical and biological research, particularly in immunology and oncology.

đŸ‘šâ€đŸ«Experience

  • Currently serving as an Associate Researcher at the First Affiliated Hospital of Soochow University, Tongguo Shi has been contributing to medical research since December 2021. Prior to this role, he worked as a Research Associate at the same institution from 2017 to 2021, where he gained extensive experience in cancer immunology and molecular medicine. He also served as a Research Associate at the Center of Systems Medicine, Chinese Academy of Medical Sciences, from 2016 to 2017, further strengthening his expertise in cellular and molecular research.

🏆Awards and Recognitions

  • Throughout his career, Tongguo Shi has established himself as a leading researcher, contributing significantly to cancer immunotherapy and colorectal cancer studies. His role as a corresponding author in multiple high-impact journal publications highlights his expertise and recognition in the scientific community. His work on immunological mechanisms in cancer and inflammatory diseases has been widely cited, demonstrating the impact of his research.

💡Skills and Certifications

  • Tongguo Shi specializes in immuno-oncology, with a focus on tumor microenvironments, immune evasion mechanisms, and cancer immunotherapy. His research has explored the role of immune checkpoints such as B7-H3 and Tim-3 in colorectal and gastric cancers, as well as the impact of microRNAs on immune regulation in inflammatory diseases. His skills include molecular biology techniques, immunological assays, cancer cell signaling analysis, and translational research aimed at developing novel therapeutic strategies.

🔬 Research Focus

  • His research has led to groundbreaking findings on the interactions between immune cells and cancer cells, with a particular emphasis on T cell-mediated immune responses. He has published extensively in prestigious journals such as Cancer Immunology, Immunotherapy, Cell Death & Disease, Mucosal Immunology, and Gut, further advancing the understanding of cancer immunology and potential therapeutic interventions.

🌎Conclusion

  • Dr. Tongguo Shi exemplifies scientific excellence and collaborative leadership in cancer research. His work has significantly advanced the understanding of tumor immunology, cancer metabolism, and immunotherapy through high-impact interdisciplinary collaborations. His strong publication record, mentorship, and institutional partnerships highlight his commitment to groundbreaking discoveries that benefit both scientific progress and patient outcomes.

📖Publications

  • Elevated SPARC Disrupts the Intestinal Barrier Integrity in Crohn’s Disease by Interacting with OTUD4 and Activating the MYD88/NF‐ÎșB Pathway
    Authors: J. Wang, Jiayu; Y. He, Yuxin; X. Zhu, Xingchao; J. Zhu, Jinghan; Z. Deng, Zilin; H. Zhang, Huan; Y. Chen, Yanjun; G. Zhang, Guangbo; T. Shi, Tongguo; W. Chen, Weichang
    Journal: Advanced Science, 2025

  • FASN Promotes Lipid Metabolism and Progression in Colorectal Cancer via the SP1/PLA2G4B Axis
    Authors: X. Liu, Xin; J. Lu, Jiachun; X. Ni, Xiangyu; Y. He, Yuxin; J. Wang, Jiayu; Z. Deng, Zilin; G. Zhang, Guangbo; T. Shi, Tongguo; W. Chen, Weichang
    Journal: Cell Death Discovery, 2025

  • Exploring the Link Between Noncoding RNAs and Glycolysis in Colorectal Cancer
    Authors: L. Xu, Liang; Y. Shen, Yu; C. Zhang, Chuanqiang; T. Shi, Tongguo; X. Sheng, Xuejuan
    Journal: Journal of Cellular and Molecular Medicine, 2025

  • The m6A Revolution: Transforming Tumor Immunity and Enhancing Immunotherapy Outcomes
    Authors: T. Shi, Tongguo; H. Zhang, Huan; Y. Chen, Yueqiu
    Journal: Cell & Bioscience, 2025

  • Exosome-Derived Proteins in Gastric Cancer Progression, Drug Resistance, and Immune Response
    Authors: J. Wang, Jiayu; H. Zhang, Huan; J. Li, Juntao; X. Ni, Xiangyu; W. Yan, Wenying; Y. Chen, Yueqiu; T. Shi, Tongguo
    Journal: Cellular & Molecular Biology Letters, 2024